11.27.2018 Issue 429

Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Round-up
The Top Story in HEOR: Latest Headlines in HEOR:

Reminder: Send ISPOR Comments on CMS
Direct-to-Consumer Ad Proposal by Friday

Monday, November 26

ISPOR is asking members to submit their comments on the Centers for Medicare and Medicaid Services’ proposed rule to require drug prices in direct-to-consumer advertisements.

Report: Pharma, U.K. Reach Deal on Pricing, Access

FDA Has Big Changes Planned for Medical Device Approval Pipeline

Patients in China Turn to Drastic Measures to Get Much-Needed Care

Apple, VA in Talks Over Portable EHRs for Veterans

CMS Looks to Launch New AI Challenge

Commentary: Medicaid Waivers Need Stronger Evaluation, RCTs a Possible Solution

ICON Webinar Spotlights Digital Health Tech, Trends

Merck KGaA, Palantir Technologies Partner in Joint Venture

FDA Releases New Proposed Framework on Drug-Related Software

Partners HealthCare, Harvard Pilgrim Merger Put on Hold

Researcher - HEOR

Executive Director, Health Technology Assessment (HTA) Statistics (U.S.)

Executive Director, Health Technology Assessment (HTA) Statistics (U.K.)

Associate Director, Health Economics & Outcomes Research

Industry Spotlight

Conferences Webinars
18th Annual Rx Drug Pricing Boot Camp
    November 27-30, Philadelphia, Pennsylvania

Bio/Pharma Summit on Nurse Educator Programs
    November 27, Philadelphia, Pennsylvania

Principles of Pharma Market Access in Europe
    December 4-5, Brussels, Belgium

Bio/Pharma Compliance Congress on Non-Promotional Activities
    December 4-5, Philadelphia, Pennsylvania

Mapping to Estimate Health-State Utility from Non-Preference-Based Outcome Measures
    November 27

New Requirements for Selling Devices in the European Union
    December 3

Population-based Care Management: How Health Plans Can Leverage PHM Solutions for Value-based Care (Part II)
    December 6

Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Orphan Drugs: European Payer Perspectives

Do Payers Really Want Pay-for-Performance?

Payer Engagement: Benchmarking Team Structure and Activity

Benchmarking Market Access Strategies for High-Cost Drugs, Biologics

Blockchain: Transformational Change for Pharma?

HTA in Europe: Key Success Factors for Positive HTA Recommendations

Paying for Digital Health: Payer Insights

Benchmarking Pharma’s MSL Capabilities

Transitioning Payment Models: Fee-for-Service to Value-Based Care

How Health Plans and Providers Can Collaborate to Improve Care Transitions and Reduce Hospital Readmissions

Generating Consensus and Trust for Quality Measurement to Support Value-Based Care

An Evidence-Based Approach to Hiring: Leaders, Physicians, Nurses, and Front Line Staff

Big Data in Pharmaceuticals: Big Opportunities or Big Challenges – or Both?

AHIP Executive Roundtable Discussion Summary

Special Thanks to Our Partners:
Evidera   HealthCore     University of FL  Xcenda   OM1
Parexel   Jefferson   Dymaxium   Precision Xtract    Pharmerit
    eMax Health   Sciformix   Evidence Partners   
ICON    Truven    
Share this newsletter on social media:

Email Twitter Facebook LinkedIn